Stem cells in the treatment of cardiovascular disease--an overview

Amita J Hotkar1, Warren Balinsky

  • 1The Milano School of Management and Urban Policy, New School University, 72 Fifth Ave, New York, NY 10011, USA. amitahotkar@gmail.com

Insights

Stem cell therapy offers a promising new strategy for treating cardiovascular diseases (CVD) by regenerating damaged heart muscle. Understanding stem cell mechanisms is crucial for effective cardiac repair and improving heart failure outcomes.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Cardiovascular diseases (CVD) cause irreversible damage to cardiomyocytes, leading to heart failure and death.
  • Current treatments for heart failure are limited, highlighting the need for novel therapeutic strategies.
  • Stem cells present a potential solution for repairing or regenerating damaged heart muscle tissue.

Purpose of the Study:

  • To explore the potential of stem cells as therapeutics for cardiovascular diseases.
  • To understand the mechanisms by which stem cells influence myocardial performance.
  • To review preliminary clinical findings and challenges in stem cell-based cardiac therapy.

Main Methods:

  • Review of preliminary clinical experiments involving stem cells for cardiac disease.
  • Analysis of stem cell properties, including proliferation and differentiation capacity.
  • Discussion of cardiovascular disease incidence, prevalence, and risk factors.

Main Results:

  • Stem cells show promise for regenerating functional heart muscle cells.
  • Understanding stem cell mechanisms is key to optimizing cell-based cardiac therapies.
  • Preliminary clinical data suggests potential benefits, alongside identified challenges.

Conclusions:

  • Stem cell therapy is a potentially groundbreaking approach for treating heart failure and other cardiovascular diseases.
  • Further research into stem cell mechanisms is essential for developing effective, rational cell-based treatments.
  • Addressing challenges in stem cell therapy will be critical for successful clinical translation.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...